Association study of lung cancer and ERCC polymorphism.

被引：0
|
作者：
Qian, L. [1 ]
Shao, M. [1 ]
Lu, D. [1 ]
机构：
[1] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China
来源：
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS | 2006年 / 47卷 / 06期
关键词：
D O I：
暂无
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [31] Breast cancer, dietary lignan intake, and CYP17 polymorphism.
    McCann, SE
    Moysich, KB
    Freudenheim, JL
    Ambrosone, CB
    Shields, PG
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S33 - S33
  • [32] Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.
    Gill, M
    Daly, G
    Heron, S
    Hawi, Z
    Fitzgerald, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 613 - 613
  • [33] Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism.
    Taioli, E
    Garte, SJ
    CANCER RESEARCH, 1996, 56 (18) : 4275 - 4275
  • [34] ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians
    Zhang, Jian
    Gu, Shi-Yang
    Zhang, Ping
    Jia, Zhen
    Chang, Jian-Hua
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (13) : 2479 - 2484
  • [35] Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer
    Liu, L.
    Li, C. H.
    Jin, T. F.
    Xu, D. Y.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 8722 - 8728
  • [36] Report. 87. On polymorphism.
    Bottger, W
    ZEITSCHRIFT FUR PHYSIKALISCHE CHEMIE-STOCHIOMETRIE UND VERWANDTSCHAFTSLEHRE, 1903, 45 (05): : 629 - 629
  • [37] Wild mice as a source of genetic polymorphism.
    Guénet, JL
    PATHOLOGIE BIOLOGIE, 1998, 46 (09): : 685 - 688
  • [38] ON UNDERSTANDING TYPES, DATA ABSTRACTION, AND POLYMORPHISM.
    Cardelli, Luca
    Wegner, Peter
    Computing surveys, 1985, 17 (04): : 471 - 522
  • [39] Population genetics of the DMA, DMB polymorphism.
    Greck, J
    Glelch, G
    Brunnler, G
    Bonisch, J
    Albert, E
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : O531 - O531
  • [40] A phase I study of irinotecan and 5′-DFUR in patients with metastatic colorectal cancer:: With consideration of gene polymorphism.
    Hazama, S
    Matoba, K
    Nagashima, A
    Matsuoka, K
    Oka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 277S - 277S
12345